Announces Regular Quarterly Cash Dividend of $0.20 Per Share Reaffirms Full-Year 2026 Revenue and Earnings Guidance Reports revenue of $22.0 million for the first quarter of 2026, an increase of $2.5 ...
Q1 2026 Earnings Call May 1, 2026 11:00 AM EDTCompany ParticipantsRoger Susi - Founder, Chairman, CEO & PresidentJohn ...
OncoRay is receiving around 1.1 million euros in funding from the Federal Ministry of Research, Technology and Space under ...
A UT Health San Antonio-led clinical trial found that MRI-guided, robotic-controlled transcranial magnetic stimulation (TMS) significantly reduced symptoms in 85% of active-duty military and veterans ...
AI is improving 1.5 Tesla MRI output, prompting hospitals to rethink expensive 3 Tesla upgrades and rebalance cost, access, and diagnostic quality.
CEM breast cancer imaging shows strong agreement with MRI and histopathology for tumour size and disease extent. Learn more.
TheNewswire - BioVaxys Technology Corp. (CSE: BIOV OTCQB:BVAXF FRA:5LB0), a clinical-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today ...
Netizens react to Blessing CEO's new test results, questioning her integrity and mental state after her previous cancer ...
Iradimed Corporation reports first-quarter results Friday, April 24, with investors watching whether the medical device specialist can sustain momentum after beating fourth-quarter expectations with ...
Approval marks a major milestone in reducing gadolinium exposure while maintaining diagnostic performance, aligning with clinical guidance to use the lowest effective dose MONTREAL, April 17, 2026 ...
A sports MD explains the overlooked causes and treatments for injuries.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results